IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

Also called NCT07746362

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
IVX Medical (from the registry)
Registry
  • NCT NCT07746362
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07746362. Allocation not applicable; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD
Acronym
HELIX-PAD
Condition
Peripheral Artery Disease (PAD)
Intervention (Device)
IV-X Medical IVL System
Lead sponsor
IVX Medical (class: industry)

Record details

Record id
cardio:ct-nct07746362
Content hash
6b50997958be07f26d590f1447133c08accd83694e74bfb9cb92500f5634d194